Abstract: Exemplary cochlear implant systems include an implantable head module configured to be implanted within a head of a patient. The implantable head module includes a cochlear stimulator configured to be coupled to an electrode lead, the electrode lead including one or more electrodes configured to be in communication with one or more stimulation sites within the patient. The implantable head module also includes a signal receiver configured to receive a telemetry signal representative of an audio signal from a signal transmitter located external to the patient, a sound processor configured to process the telemetry signal and direct the cochlear stimulator to generate and apply electrical stimulation representative of the audio signal to the one or more stimulation sites via the electrode lead, and a power receiver configured to receive power for operating the implantable head module from a power transmitter located external to the patient.

Abstract: This invention relates to the healthcare industry and to a novel non-invasive body surface bipolar ECG to monitor the action potential (AP) of the myocardium muscle. The invention uses surface ECG signals to deduce information on the cardiac ion channels, founded on the reconstruction of the epicardial ECG T-wave using a single transfer filter function of the frequency domain. Ion channels conductances obtained are then used to calculate action potential EndAP, EpiAP and MAP of the myocardium. These APs values can in turn be used to calculate post drug transmural dispersion of repolarisation values to giving an indication of possible cardiac arrhythmias. The invention further relates to various apparatus for carrying out the invention, including an array of bipolar electrodes which in use is arranged on the body surface so as to comprise multiples of orthogonally bisecting electrodes.

Abstract: In an embodiment, a lead system includes a cuff electrode to secure to a nerve, a first lead portion defining a longitudinal axis, and a second lead portion. An anchor may be between the first lead portion and the second lead portion to secure to non-nerve structure. A connector may extend from the second lead portion to connect to a pulse generator. Electrode elements are spaced apart along the cuff body. The cuff electrode may include a first resilient arcuate-shaped portion extending in a first circumferential direction and having a first arc length; and a second resilient arcuate-shaped portion integrally formed with the first arcuate-shaped portion, extending in a second circumferential direction, and having a second arm length greater that the first arc length. The second arcuate-shaped portion overlaps the first arcuate-shaped portion, The first and second arcuate-shaped portions define a lumen having a substantially re-closable opening.

Abstract: An apparatus for reversing ventricular remodeling with electro-stimulatory therapy. A ventricle is paced by delivering one or more stimulatory pulses in a manner such that a stressed region of the myocardium is pre-excited relative to other regions in order to subject the stressed region to a lessened preload and afterload during systole. The unloading of the stressed myocardium over time effects reversal of undesirable ventricular remodeling.

Abstract: In one embodiment, a method of treating an upper airway may include delivering a first electrical stimulation to a first portion of a nerve innervating a first upper airway muscle via a plurality of electrodes adjacent the nerve. The method may further include delivering a second electrical stimulation to a second portion of the nerve innervating a second upper airway muscle via the plurality of electrodes, wherein the second muscle is different from the first muscle.

Abstract: An implantable medical device includes an acoustic transducer for intra-body communication with another medical device via an acoustic couple. The acoustic transducer includes one or more piezoelectric transducers. In one embodiment, an implantable medical device housing contains a cardiac rhythm management (CRM) device and an acoustic communication circuit. The acoustic communication circuit includes an error detection circuit configured for detecting an error rate associated with demodulated incoming acoustic signals and a frequency selection circuit configured for adjusting a carrier frequency of outbound acoustic signals. The acoustic transducer is electrically connected to the acoustic communication circuit to function as an acoustic coupler and physically fastened to a wall of the implantable housing, directly or via a supporting structure.

Abstract: An implantable electrode array (30) that can adopt a first configuration selected to allow the array (30) to be inserted into a cochlea (12) of an implantee and at least a second configuration in which the array can apply tissue stimulation. The array (30) comprises an elongate carrier (31) having a proximal end (37), a distal end (34), and an inner surface (35) conformable with the inner wall of the implantee's cochlea (12). A plurality of electrodes (36) are supported within the carrier (31) at respective spaced locations thereon in a region between the proximal end (37) and the distal end (34) with at least one of the electrodes having a surface that is at least adjacent the inner surface (35) of the carrier (31). The carrier (31) is formed in the second configuration from a first layer (32) and at least a second layer (32) of resiliently flexible material. Manufacturing methods include molding the first and second layers into an array such as that described above.

Abstract: The stimulation provided in the electrically stimulated cochlea is modulated in accordance with the amplitude of a received acoustic signal and the onset of a sound in a received acoustic signal to provide increased sound perception. An onset time that corresponds to the onset of a sound is detected in an acoustic signal associated with a frequency band. A forcing voltage and a transmitting factor are determined, wherein the forcing voltage and the transmitting factor are associated with the frequency band at the detected onset time. The acoustic signal is modulated as a function of the forcing voltage and the transmitting factor to generate an output signal. The generated output signal can be used to stimulate the cochlea. The modulation strategy can be used in conjunction with sound processing strategies that employ frequency modulation, amplitude modulation, or a combination of frequency and amplitude modulation.

Abstract: A TET system is operable to vary an amount of power transmitted from an external power supply to an implantable power unit in accordance with a monitored condition of the implantable power unit. The amount of power supplied to the implantable power unit for operating a pump, for example, can be varied in accordance with a cardiac cycle, so as to maintain the monitored condition in the power circuit within a desired range throughout the cardiac cycle.

Abstract: Embodiments of the present invention relate to implantable systems, and method for use therein, that can detect myocardial ischemic events. In accordance with specific embodiments of the present invention, short-term fluctuations in cardiac intervals that follow premature ventricular contractions (PVCs) are monitored. This allows myocardial ischemic events to be detected based on these monitored fluctuations. The cardiac intervals for which fluctuations are being monitored can be, for example, RR intervals. Alternatively, or additionally, short-term fluctuations in other types of cardiac intervals may be monitored. Such other cardiac intervals include, for example, PR intervals, PP intervals, QT intervals and RT intervals.

Abstract: In a device (1) for the defibrillation of a heart (2) with an implantable cardiac pacemaker and defibrillator (3), the defibrillation electrode (4) is arranged on the stimulation electrode (5), with the stimulation electrode enclosing the defibrillation electrode. In order to be able to remove the defibrillation electrode without a complicated operation if a defect in the defibrillation electrode (4) occurs during use, it can be moved relative to the stimulation electrode (5) and can be retracted and replaced relative to the implanted stimulation electrode (5) from its position of use, for which the stimulation electrode (5) can be detached or separated from the cardiac pacemaker (3) or its plug (9) provided on this pacemaker.

Abstract: An improved implantable pulse generator (IPG) containing improved telemetry circuitry is disclosed. The IPG includes charging and telemetry coils within the IPG case, which increases their mutual inductance and potential to interfere with each other; particularly problematic is interference to the telemetry coil caused by the charging coil. To combat this, improved telemetry circuitry includes decoupling circuitry for decoupling the charging coil during periods of telemetry between the IPG and an external controller. Such decoupling circuitry can comprise use of pre-existing LSK circuitry during telemetry, or new discrete circuitry dedicated to decoupling. The decoupling circuitry is designed to prevent or at least reduce induced current flowing through the charging coil during data telemetry.

Abstract: An audio prostheses having a set of operating parameters is fit to an implanted patient. An audio stimulation pattern is initiated to the audio prosthesis. A fit adjustment process is performed during the audio stimulation pattern, which includes: changing a set of selected operating parameter values. Patient feedback is received that indicates a subjective performance evaluation of operation of the audio prosthesis. The process is repeated (e.g., continuously) to collect performance evaluation data related to the operating parameter values. Then the operating parameters are set based on the performance evaluation data.

Abstract: An automatic external defibrillator (AED) includes an integral wireless modem configured so that, upon activation, the AED automatically connects to a wireless network and reports the event to an emergency services center or remote server to call for an ambulance. The activation report may be accomplished by calling an emergency services center and playing a prerecorded voice message that includes AED location information. Alternatively, the activation report may be transmitted via a wireless data network to a remote server which routes the information to appropriate authorities. After the activation report is transmitted, the AED may transmit patient and treatment data to the server. The AED may include a speaker phone capability so a caregiver can talk with a dispatcher or medical team. The AED may also automatically report activation data and periodic self-diagnostic testing results to a manufacturer or service provider via a wireless data call to a remote server.

Abstract: A heart rate monitor generates an ST deviation time series by employing a recursive filter that is preferably an exponential average filter whose output is a weighted sum of the then existing ST time series value and current ST deviation values of analyzable beats. Beats are detected in segments of data. ST deviation is measured for analyzable beats. The ST deviation time series is updated only if certain criteria are met. A first criterion for updating the time series is that at least half of the beats within a segment must be normal sinus rhythm beats. A second criterion for updating the time series is that (i) the average RR interval of the segment is between ¾ and 1.5 times the average RR interval of the previous segment; or (ii) both (a) the number of abnormal beats in the current segment is less than 2, and (b) the number of premature ventricular contractions within the current segment is less than 2.

Abstract: An active implantable medical device of the cardiac prosthesis type, including antitachycardia atrial pacing and antibradycardia ventricular pacing therapies. The device includes circuits and control logic for detecting electrical atrial and ventricular spontaneous events (R), delivering low energy antitachycardia atrial pacing, and antibradycardia ventricular pacing, and able to deliver a ventricular pacing (V) in the absence of a detected spontaneous ventricular event (R) after a calculated ventricular escape interval (IE). The device includes a sensor delivering an endocardiac acceleration signal (EA) representative of the movements produced by the contractions of the ventricle.

Abstract: Implantable systems, and methods for use therein, perform at least one of a cardiac assessment and an autonomic assessment. Premature atrial contractions (PACs) are induced to thereby cause corresponding premature contractions in the ventricles. Short-term fluctuations in cardiac intervals, that follow the premature contractions in the ventricles caused by the induced PACs, are monitored. At least one of a cardiac assessment and an autonomic assessment is performed based on the monitored fluctuations in cardiac intervals that follow the premature contractions in the ventricles caused by the induced PACs. This can include assessing a patient's risk of sudden cardiac death (SCD), assessing a patient's autonomic tone and/or detecting myocardial ischemic events based on the monitored fluctuations in cardiac intervals that follow the premature contractions in the ventricles caused by the induced PACs.

Abstract: A retinal prosthesis with an inductive coil mounted to the side of the eye by using a strap around the eye. This allows for close coupling to an external coil and movement of the entire implanted portion with movement of the eye ball.

Abstract: Systems and methods for treating at least one of a plurality of disorders characterized at least in part by vagal activity.

Abstract: Systems and methods of using a system for treating a gastrointestinal disorder characterized by dysmotility of a gastrointestinal organ.